These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8317066)

  • 41. [Reactivation of pulmonary tuberculosis and elimination of bacilli].
    Rudoĭ NM; Asambaev AA; Eliseev VV
    Klin Med (Mosk); 1970 Dec; 48(12):27-31. PubMed ID: 4996608
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
    Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some healthy skepticism about inhaled therapy for tuberculosis.
    Iseman MD
    Clin Infect Dis; 2001 Jul; 33(2):266-7. PubMed ID: 11418891
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Drug resistance in Mycobacteria tuberculosis in the Barents region of Russia and Norway].
    Mar'iandyshev AO; Tungusova OS; Kaugan D; Sandven P
    Probl Tuberk; 2002; (2):41-3. PubMed ID: 11899806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunological studies in tuberculous patients resistant to specific treatment (author's transl)].
    Cicero R; Bernal MA; Celis ME; de la Escosura G; Olivares A; Pacheco CR
    Rev Invest Clin; 1980; 32(3):259-70. PubMed ID: 6777847
    [No Abstract]   [Full Text] [Related]  

  • 49. [Resistance of Mycobacterium tuberculosis strains isolated from patients to antituberculosis drugs].
    Sybirna RI; Iavors'ka GV
    Mikrobiol Z; 2001; 63(4):91-5. PubMed ID: 11692684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.
    Ann Pharmacother; 2006 May; 40(5):1007-8. PubMed ID: 16670365
    [No Abstract]   [Full Text] [Related]  

  • 52. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnosis of pulmonary tuberculosis].
    Herrera Contreras M; Villegas Bobadilla A
    Salud Publica Mex; 1982; 24(3):289-93. PubMed ID: 6815812
    [No Abstract]   [Full Text] [Related]  

  • 54. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP
    Probl Tuberk; 1998; (4):4-5. PubMed ID: 9771024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reinfection with multidrug-resistant tuberculosis.
    Lin BT
    N Engl J Med; 1993 Sep; 329(11):811-2. PubMed ID: 8350907
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis].
    Rinder H
    Pneumologie; 1998 Feb; 52(2):91-2. PubMed ID: 9557056
    [No Abstract]   [Full Text] [Related]  

  • 58. [Surgical treatment for hardly curable cases of pulmonary tuberculosis].
    Ota M; Shinoda A; Yoshida T; Hitota N; Suetsugu S
    Kekkaku; 1971 Jul; 46(7):251-7. PubMed ID: 5000368
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug resistant pulmonary tuberculosis: problems of diagnosis and treatment in hospital conditions].
    Suslov VA; Moskalenko VA
    Voen Med Zh; 2002 May; 323(5):26-30, 112. PubMed ID: 12073833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is second-line anti-tuberculosis drug susceptibility testing reliable?
    Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.